269 related articles for article (PubMed ID: 35717177)
1. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
[TBL] [Abstract][Full Text] [Related]
2. Photobiomodulation Can Prevent Medication-Related Osteonecrosis of the Jaw Formation in Tooth Extraction Site of Rat Model.
Chegini L; Bastami F; Mashhadi-Abbas F; Chegini R; Hadadi-Ahangarkolaee Z; Fekrazad R; Gholampour Dehaki M
Photobiomodul Photomed Laser Surg; 2024 Apr; 42(4):285-293. PubMed ID: 38662503
[No Abstract] [Full Text] [Related]
3. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
Parise GK; Costa BN; Nogueira ML; Sassi LM; Schussel JL
Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
[TBL] [Abstract][Full Text] [Related]
4. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.
Besi E; Pitros P
Oral Maxillofac Surg; 2024 Jun; 28(2):785-793. PubMed ID: 38182917
[TBL] [Abstract][Full Text] [Related]
5. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
[TBL] [Abstract][Full Text] [Related]
6. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
[TBL] [Abstract][Full Text] [Related]
7. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin.
Özalp Ö; Yıldırımyan N; Öztürk C; Kocabalkan B; Şimşek Kaya G; Sindel A; Altay MA
BMC Oral Health; 2021 Dec; 21(1):613. PubMed ID: 34852823
[TBL] [Abstract][Full Text] [Related]
8. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats.
Statkievicz C; Toro LF; de Mello-Neto JM; de Sá DP; Casatti CA; Issa JPM; Cintra LTA; de Almeida JM; Nagata MJH; Garcia VG; Theodoro LH; Ervolino E
J Photochem Photobiol B; 2018 Jul; 184():7-17. PubMed ID: 29777942
[TBL] [Abstract][Full Text] [Related]
9. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
Giudice A; Antonelli A; Muraca D; Fortunato L
Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
[TBL] [Abstract][Full Text] [Related]
11. Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw.
Yalcin-Ülker GM; Duygu G; Tanan G; Cakir M; Meral DG
J Craniofac Surg; 2023 May; 34(3):1039-1044. PubMed ID: 36627754
[TBL] [Abstract][Full Text] [Related]
12. Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study.
Tenore G; Zimbalatti A; Rocchetti F; Graniero F; Gaglioti D; Mohsen A; Caputo M; Lollobrigida M; Lamazza L; De Biase A; Barbato E; Romeo U
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33138266
[TBL] [Abstract][Full Text] [Related]
13. Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF.
Bouland C; Meuleman N; Widelec J; Keiani-Mothlagh K; Voisin C; Lagneaux L; Philippart P
J Stomatol Oral Maxillofac Surg; 2021 Apr; 122(2):212-218. PubMed ID: 32540361
[TBL] [Abstract][Full Text] [Related]
14. Use of Leukocyte- and Platelet-Rich Fibrin in the Treatment of Medication-Related Osteonecrosis of the Jaws.
Maluf G; Caldas RJ; Silva Santos PS
J Oral Maxillofac Surg; 2018 Jan; 76(1):88-96. PubMed ID: 28675810
[TBL] [Abstract][Full Text] [Related]
15. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.
Fernando de Almeida Barros Mourão C; Calasans-Maia MD; Del Fabbro M; Le Drapper Vieira F; Coutinho de Mello Machado R; Capella R; Miron RJ; Gomes Alves G
J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):84-89. PubMed ID: 30794883
[TBL] [Abstract][Full Text] [Related]
16. Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?
Park JH; Kim JW; Kim SJ
J Oral Maxillofac Surg; 2017 Jun; 75(6):1176-1184. PubMed ID: 28042979
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaw induced by bisphosphonates therapy in bone metastases patient: Case report and literature review.
Hao L; Tian Z; Li S; Yan K; Xue Y
Oral Oncol; 2022 May; 128():105852. PubMed ID: 35439709
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.
Tartaroti NC; Marques MM; Naclério-Homem MDG; Migliorati CA; Zindel Deboni MC
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101651. PubMed ID: 31923636
[TBL] [Abstract][Full Text] [Related]
19. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
[No Abstract] [Full Text] [Related]
20. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
